InfuSystem Holdings Sets Annual Meeting Date
Ticker: INFU · Form: 8-K · Filed: May 17, 2024 · CIK: 1337013
| Field | Detail |
|---|---|
| Company | Infusystem Holdings, INC (INFU) |
| Form Type | 8-K |
| Filed Date | May 17, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: annual-meeting, corporate-governance
Related Tickers: INFU
TL;DR
InfuSystem Holdings (INFU) holding its annual shareholder meeting June 27th - vote on directors!
AI Summary
InfuSystem Holdings, Inc. announced on May 16, 2024, that it will hold its 2024 Annual Meeting of Stockholders on June 27, 2024. The meeting will include a vote on the election of directors and other business matters. The company's principal executive offices are located at 3851 West Hamlin Road, Rochester Hills, Michigan.
Why It Matters
This filing informs shareholders about the upcoming annual meeting where key corporate decisions, including director elections, will be made, impacting the company's future direction.
Risk Assessment
Risk Level: low — This is a routine corporate filing announcing a shareholder meeting date and not related to significant financial or operational changes.
Key Players & Entities
- InfuSystem Holdings, Inc. (company) — Registrant
- June 27, 2024 (date) — Annual Meeting Date
- May 16, 2024 (date) — Date of Report
- 3851 West Hamlin Road, Rochester Hills, Michigan (location) — Principal Executive Offices
FAQ
When is InfuSystem Holdings, Inc.'s 2024 Annual Meeting of Stockholders?
The 2024 Annual Meeting of Stockholders is scheduled for June 27, 2024.
What is the primary purpose of the meeting announced in this 8-K?
The primary purpose is to hold the 2024 Annual Meeting of Stockholders, which will include a vote on the election of directors and other business matters.
What is the filing date of this Current Report on Form 8-K?
The filing date of this report is May 17, 2024, and the date of the earliest event reported is May 16, 2024.
Where are InfuSystem Holdings, Inc.'s principal executive offices located?
The principal executive offices are located at 3851 West Hamlin Road, Rochester Hills, Michigan 48309.
What is the Commission File Number for InfuSystem Holdings, Inc.?
The Commission File Number for InfuSystem Holdings, Inc. is 001-35020.
Filing Stats: 587 words · 2 min read · ~2 pages · Grade level 12.6 · Accepted 2024-05-17 16:53:06
Filing Documents
- infu-20240516.htm (8-K) — 40KB
- 0001628280-24-024122.txt ( ) — 161KB
- infu-20240516.xsd (EX-101.SCH) — 2KB
- infu-20240516_lab.xml (EX-101.LAB) — 21KB
- infu-20240516_pre.xml (EX-101.PRE) — 12KB
- infu-20240516_htm.xml (XML) — 3KB
07 - Submission of Matters to a Vote of Security Holders
Item 5.07 - Submission of Matters to a Vote of Security Holders At the 2024 Annual Meeting of Stockholders of InfuSystem Holdings, Inc. (the "Company") held on May 16, 2024 , the matters voted upon and the number of votes for, against or withheld, as well as the number of abstentions and broker non-votes as to such matters, were as stated below: Proposal No. 1: The Company's Board Nominees For Withheld Broker Non-Votes Ralph Boyd 10,321,961 5,543,688 2,409,394 Richard DiIorio 12,564,229 3,301,420 2,409,394 Kenneth Eichenbaum 11,444,647 4,421,002 2,409,394 Paul Gendron 11,366,680 4,498,969 2,409,394 Beverly Huss 10,958,717 4,906,932 2,409,394 Carrie Lachance 12,443,248 3,422,401 2,409,394 Scott Shuda 9,810,697 6,054,952 2,409,394 All seven of the Company's Board nominees (Messrs. Boyd, DiIorio, Eichenbaum, Gendron and Shuda and Mss. Huss and Lachance) were elected to the Board. Proposal No. 2: The Company's stockholders approved, on a non-binding, advisory basis, the compensation of the Company's named executive officers as disclosed in the Company's proxy statement as follows: For Against Abstain Broker Non-Votes 8,447,458 7,411,428 6,763 2,409,394 Proposal No. 3: The Company's stockholders ratified the appointment of Deloitte & Touche LLP as the Company's registered independent accounting firm for the fiscal year ending December 31, 2024 as follows: For Against Abstain Broker Non-Votes 16,164,598 1,930,216 180,229 0
01 - Financial Statements and Exhibits
Item 9.01 - Financial Statements and Exhibits (d) Exhibits Exhibit No. Description 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934 the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. INFUSYSTEM HOLDINGS, INC. By: /s/ Barry Steele Barry Steele Chief Financial Officer Dated: May 17, 2023